The body composition profile is associated with response to anti- TNF therapy in Crohn's disease and may offer an alternative dosing paradigm.

Autor: Ding, N. S.1,2,3 dingnik@gmail.com, Malietzis, G.1,2, Lung, P. F. C.1, Penez, L.1, Yip, W. M.1, Gabe, S.1,2, Jenkins, J. T.1,2, Hart, A.1,2
Zdroj: Alimentary Pharmacology & Therapeutics. Nov2017, Vol. 46 Issue 9, p883-891. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje